Stem cell therapy for thin uterine lining or scarring
Part of Women’s health & pregnancy clinical trials.
This trial tests a new treatment for people with a thin uterine lining or uterine scarring that hasn't responded to other stem cell therapy. It might help improve the lining so pregnancy is possible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a thin uterine lining (less than 6 mm) or moderate to severe uterine scarring (adhesions).
- You have tried a stem cell treatment with your own bone marrow cells (BMSC) and it either couldn't be done or didn't work well.
- You want to become pregnant.
- Your ovaries are working normally, or you have frozen embryos stored.
- Your body mass index (BMI) is between 18 and 30.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new liquid dressing made from human cells to see if it is safe and helps heal moderate to severe uterine scarring (intrauterine adhesions) in women who want to have children. Participants will receive the dressing during a hysteroscopic procedure.
This trial tests a new treatment using stem cell particles (exosomes) to help rebuild the lining of the womb in women whose lining is too thin after surgery for scar tissue. It may improve chances of success with IVF.
This trial tests if injecting a patient's own bone marrow stem cells into the uterus can help grow the lining in women with severe scarring and infertility. It might offer a new option for those who have not been able to have a frozen embryo transfer because their uterine lining stays too thin.
This early-phase study tests whether mobilized stem cells from bone marrow can help women with certain abnormal uterine lining problems become healthier and possibly improve fertility. It’s aimed at people who are not pregnant and meet specific diagnoses and test results.
This study tests if a special treatment made from cord blood can help women with a thin uterine lining (the inner layer of the womb) or Asherman syndrome (scar tissue). The goal is to see if it can improve the lining so it's healthier for pregnancy.
This trial tests whether infusing a growth factor (G-CSF) into the uterus can help women with a thin uterine lining (≤7 mm) before embryo transfer. The goal is to improve pregnancy chances.
Hear when a new Endometrium; Atrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.